FDA Adverse Event
Injury
Summary report: N
AVELI
MDR report key: 19016503
·
Received April 1, 2024
Report
- Report Number
- 3020889437-2024-00002
- Event Type
- Injury
- Date Received
- April 1, 2024
- Date of Event
- March 4, 2024
- Report Date
- March 26, 2024
- Manufacturer
- REVELLE AESTHETICS, INC.
- Product Code
- OUP
- UDI-DI
- 00850036790006
- PMA / PMN Number
- K232153
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TX, US
- Reporter Occupation
- 117
Narratives
Description of Event or Problem · 0
IT WAS REPORTED THAT 22 CELLULITE DEPRESSIONS WERE TREATED WITH AVELI, AND, APPROXIMATELY 4 WEEKS AFTER THE PROCEDURE, 30 CC'S OF FLUID WERE DRAINED FROM A SEROMA ON THE BUTTOCKS. IT WAS REPORTED THAT THREE DAYS LATER, 25 CC'S OF FLUID WERE DRAINED FROM A LARGER SEROMA ON THE BUTTOCKS, AND A FEW SMALL AREAS WERE DRAINED ON THE POSTERIOR SIDE. NODULES WERE ALSO REPORTED AND ARE DISSIPATING WITH MASSAGE AS OF ONE MONTH POST PROCEDURE. SIGNIFICANT BRUISING WAS REPORTED ON DAY 2 AFTER THE AVELI TREATMENT. COMPRESSION GARMENTS WERE WORN FOR TWO WEEKS AFTER THE PROCEDURE. THE BRUISING IS REPORTED TO BE ONGOING APPROXIMATELY ONE MONTH AFTER THE PROCEDURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1867262 | AVELI | AVELI | OUP | REVELLE AESTHETICS, INC. | NC83823002 | 00850036790006 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 42 YR | Female | Required Intervention |